Quantcast

Latest Statin Stories

2014-04-01 23:01:23

The Firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. New York, New York (PRWEB) April 01, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) filed on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin continue to mount in federal court, Bernstein Liebhard LLP notes the release of two new studies which suggest...

2014-04-01 08:28:50

New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 1, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first Phase 2 study with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), in Japanese patients met its primary endpoint. The results...

2014-03-31 12:28:14

Data demonstrates that the NMR LipoProfile® test provides clinically reliable information to help reduce cardiovascular events, especially in patients with diabetes and those on statin therapy WASHINGTON, March 31, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data showing that...

2014-03-31 12:07:41

In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. The American...

2014-03-31 12:02:52

Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. The common approach in cardiovascular disease (CVD) primary...

2014-03-31 09:39:28

Popular cholesterol-lowering drugs may offer added benefit for men with erectile dysfunction Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. Erectile dysfunction is common in older men, especially among those with cardiovascular risk factors...

2014-03-29 16:20:11

Data From Three Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented as Featured Clinical Research at ACC.14 THOUSAND OAKS, Calif., March 29, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C)...

2014-03-28 08:26:53

U.S. Healthcare Professionals Now Can Perform Lab-Accurate Lipid and Liver Diagnostics with a simple fingerstick using the Piccolo® Blood Chemistry Analyzer. UNION CITY, Calif., March 28, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Food and Drug Administration granted CLIA waived status for capillary draw for CHOL, HDL and TRIG. Combined with existing CLIA waived tests for...

Key To Curbing Lifetime Heart Disease Risk Is Knowing True Age Of Your Heart
2014-03-27 13:31:06

BMJ-British Medical Journal Part of new risk assessment which aims to put patients in driving seat and start prevention early The Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3), which have been drawn up by 11 UK professional societies and charitable organizations, are based on the latest available scientific evidence. They emphasize the importance of putting patients in the driving seat and starting preventive action early on,...

2014-03-27 04:20:44

Companies to Host Investor Conference Call on Alirocumab on March 31 at 9 AM EDT PARIS and TARRYTOWN, N.Y., March 27, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from alirocumab clinical studies will be presented at the American College of Cardiology's (ACC) 63rd Annual Scientific Session in Washington, D.C. March 29-31. Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related